We test the hypothesis that a closely related peptide, pituitary adenylate cyclase-activating peptide (PACAP-38), works independently of CGRP and thus might represent a new alternative drug target. Methods: We used mouse models of provoked migraine-like pain based upon multiple stimulations and subsequent measurement of tactile sensitivity responses. The gene discussed is ADCYAP1; the disease is migraine disorder.